If Joe Manchin does not get his act together about ensuring that every day Americans for a change get the appropriate support from their government, we will remind all that his daughter is a major part of the cesspool that is the pharmaceutical industry that is ripping his constituents off. The least he must do is support the $2000 stimulus/relief for every American.
CEO at center of EpiPen price hike controversy is Sen. Joe Manchin’s daughter - The Washington Post
The growing congressional scrutiny of pharmaceutical giant Mylan over the high cost of EpiPens could prove awkward for Sen. Joe Manchin.
The West Virginia Democrat’s daughter, Heather Bresch, is chief executive of the company, which appears to have hiked the price of the epinephrine auto-injector by 400 percent since 2007. The device, which is used to treat severe allergic reactions, now costs more than $600 per dose.
This price increase has become a public relations disaster for Mylan and at least four of Manchin’s Senate colleagues are either pressing the company to reduce the cost of EpiPens, asking it to explain the price increase or requesting federal regulators to investigate the matter. Manchin is not a member of the Senate Judiciary Committee, which has shown the most interest in probing Mylan’s pricing practices, and so far the senator is not discussing the issue.
“Right now we don’t have any comment,” Manchin spokesman Jon Kott said in an email Tuesday.
Senate Judiciary Committee Chairman Charles E. Grassley (R-Iowa) on Monday sent a letter to Bresch requesting information about how Mylan determined the price of EpiPens and whether the company provides assistance to patients to help with the cost. Grassley said he has heard concerns about the high cost of EpiPens from many constituents, including a man in Iowa who recently had to pay more than $500 to refill his daughter’s EpiPen prescription. The letter asks the company to respond by Sept. 6. Congress is out of session until after Labor Day.